Drawing for CHECKPOINT THERAPEUTICS

USPTO serial 86498366

CHECKPOINT THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WHITE, RICHARD F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHECKPOINT THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Devon E. White

DEVON E. WHITE Wyrick Robbins Yates & Ponton Llp4101 Lake Boone Trl Ste 300Raleigh, NC 27607-7525UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 17, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 17, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 24, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 24, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 6, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 5, 2018EX5GSOU EXTENSION 5 GRANTED—
Feb 2, 2018EXT5SOU EXTENSION 5 FILED—
Feb 2, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 12, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 10, 2017EX4GSOU EXTENSION 4 GRANTED—
Aug 10, 2017EXT4SOU EXTENSION 4 FILED—
Aug 10, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2017EX3GSOU EXTENSION 3 GRANTED—
Jan 12, 2017EXT3SOU EXTENSION 3 FILED—
Jan 12, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 18, 2016EX2GSOU EXTENSION 2 GRANTED—
Aug 18, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 21, 2016EXT2SOU EXTENSION 2 FILED—
Jul 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 14, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2016EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2016EXT1SOU EXTENSION 1 FILED—
Jan 12, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 8, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 6, 2015ALIEASSIGNED TO LIE—
Apr 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 14, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Apr 14, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 14, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 14, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 14, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2015DOCKASSIGNED TO EXAMINER—
Jan 20, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance